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Isothiourea HBTM-2.1 catalyses the Michael addition-lactonisation of 2-aryl and 2-
alkenylacetic acids and ,-unsaturated trichloromethyl ketones. Ring-opening of the resulting 
dihydropyranones and subsequent alcoholysis of the CCl3 group with an excess of methanol 
gives a range of diesters in high diastereo- and enantioselectivity (up to 95:5 dr and >99% ee). 
Sequential addition of two different nucleophiles to a dihydropyranone gives the corresponding 
differentially substituted diacid derivative.  
 
 
 
Introduction 
Lewis base organocatalysis is a powerful method for the 
stereoselective construction of carbon-carbon bonds.1 In this 
regard, catalytic asymmetric conjugate additions of ammonium 
and azolium enolates to electron-deficient alkenes have been 
widely explored.2,3 However, the use of α,β-unsaturated esters 
and amides as Michael acceptors in such processes remains a 
challenge due to the decreased electrophilicity of such 
substrates. Strategies to overcome this problem typically make 
use of more reactive α,β-unsaturated ester equivalents such as 
N-acylpyrroles 1,4 2-acyl imidazoles 2,5 activated imides 36 and 
-ketophosphonates 4 (Fig. 1i).7,8 
We have previously reported a number of intra- and 
intermolecular isothiourea-catalysed Michael addition-
cyclisation cascades of electron-deficient Michael acceptors 
with ammonium enolates generated from carboxylic acids.9-12 
Of particular relevance is our recent report on the use of -
keto-β,γ-unsaturated phosphonates as ester equivalents in an 
intermolecular Michael addition-lactonisation reaction, giving 
access to a range of diester products with high levels of 
stereoselectivity after ring-opening and alcoholysis.13 However, 
many -keto-β,γ-unsaturated phosphonates are not bench-stable 
and cannot be stored for long periods of time. To alleviate this 
problem the use of α,β-unsaturated trichloromethyl ketones as 
alternative, bench-stable α,β-unsaturated ester equivalents 
seemed an attractive possibility.  
Trichloromethyl ketones are versatile synthetic building 
blocks and have been used as carboxylic acid, ester and amide 
equivalents by utilising the leaving group ability of the CCl3 
group in haloform-type reactions.14,15 For example, Friedel-
Crafts acylation of heterocycles, in particular pyrrole 
derivatives, using trichloroacetyl chloride followed by 
substitution of the CCl3 group with either alcohol or amine 
nucleophiles is a widely used reaction sequence in natural 
product synthesis.16,17 Shibasaki and co-workers have used 
trichloromethyl ketones as ester and amide-enolate equivalents 
in diastereoselective Mannich reactions, with the electron-
withdrawing nature of the CCl3 group allowing catalytic α-
deprotonation to form an enolate.18  
α,β-Unsaturated trichloromethyl ketones have previously 
been used as ester and amide equivalents of Michael acceptors 
in a small number of processes.19 For example, Zhao and co-
workers reported the two-step enantioselective diaryl prolinol 
catalysed epoxidation of α,β-unsaturated trichloromethyl 
ketones using tert-butylhydroperoxide (TBHP) followed by 
either alcoholysis with methanol or aminolysis with various 
amines.19a Zhao and co-workers have also reported Michael 
additions of α-cyano ketones into α,β-unsaturated 
trichloromethyl ketones catalysed by a piperazine/thiourea 
based bifunctional organocatalyst.19b More recently, Wang et 
al. have performed enantioselective vinylogous Michael 
additions of α,β-unsaturated γ-butyrolactams into α,β-
unsaturated trichloromethyl ketones using a chiral quinine-
derived squaramide organocatalyst, followed by methanolysis 
of the CCl3 group.
19c 
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Fig. 1 i) Previously used α,β-unsaturated ester equivalents. ii) Proposed use of 
α,β-unsaturated trichloromethyl ketones in asymmetric intramolecular Michael 
addition-lactonisations  
 
Herein an isothiourea-catalysed Michael addition-lactonisation 
process using 2-aryl and 2-alkenylacetic acids and bench-stable 
α,β-unsaturated trichloromethyl ketones as ester and amide 
equivalents is reported (Fig. 1ii). Nucleophilic ring-opening of 
the initially formed dihydropyranone products followed by 
either alcoholysis or aminolysis of the CCl3 group gives access 
to stereodefined diesters and diamides, respectively. 
Furthermore in a single example, a relatively slow alcoholysis 
of the CCl3 group compared to dihydropyranone ring-opening 
allowed the sequential addition of two different nucleophiles, 
leading to the formation of a differentially substituted diacid 
derivative. This is in contrast to the use of -keto-β,γ-
unsaturated phosphonates where both ring-opening and either 
alcoholysis or aminolysis of the phosphate group proceeds 
rapidly and differential functionalisation is not possible.13  
Results and discussion 
α,β-Unsaturated trichloromethyl ketone synthesis 
First, the reaction of phenylacetic acid 6 with (E)-1,1,1-
trichloro-4-phenylbut-3-en-2-one 7 was studied. 
Trichloromethyl ketone 7 was synthesised on gram-scale using 
a two-step procedure first described by Corey and co-workers.20 
Nucleophilic addition of the CCl3 anion, generated from 
trichloroacetic acid and sodium trichloroacetate in N,N-
dimethylformamide (DMF), into (E)-cinnamaldehyde followed 
by Swern oxidation of the resulting trichloromethyl carbinol 
gave trichloromethyl ketone 7 in 45% yield (4.41 g, 18 mmol) 
over the two steps. This robust protocol was used for the gram-
scale preparation of a range of α,β-unsaturated trichloromethyl 
ketones, which can be readily stored on the bench-top without 
undergoing decomposition.21 An alternative method of 
synthesising 7 using (E)-cinnamaldehyde and CHCl3 in the 
presence of KOH, followed by oxidation, was unreliable in our 
hands, with the formation of polymeric mixtures during the first 
step resulting in low yields.19a  
 
Initial studies 
Reaction of trichloromethyl ketone 7 with phenylacetic acid 6 
(1.5 eq), using pivaloyl chloride (2.25 eq) to form an in situ 
mixed anhydride, in the presence of isothiourea HBTM-2.1 5 (5 
mol%) and i-Pr2NEt (1.5 eq) at –78 °C gave dihydropyranone 8 
in 82% yield as a 87:13 mixture of diastereoisomers, with the 
major anti-diastereoisomer formed in excellent 99% ee 
(Scheme 1).22-24 Attempted nucleophilic ring-opening of 
dihydropyranone 8 with one equivalent of methanol and a 
catalytic amount of DMAP (20 mol%) led to the unexpected 
formation of pyranone 9 in 65% yield, presumably through 
deprotonation to eliminate HCl followed by tautomerisation. 
Pleasingly, treating dihydropyranone 8 with a large excess of 
methanol in the presence of DMAP (20 mol%) led to the 
desired ring-opening and alcoholysis of the CCl3 group to give 
a single diastereoisomer of diester 10 in 62% yield and 99% ee 
after purification by column chromatography. The absolute and 
relative stereochemistry of diester 10 was confirmed by 
comparison of data with that previously reported, with all 
subsequent compounds assigned by analogy.13 
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Scheme. 1 
a
 Isolated yield of a mixture of diastereoisomers. 
b
 Determined by 
1
H 
NMR spectroscopic analysis of the crude reaction mixture. 
c
 Determined by chiral 
HPLC analysis of diester 10. d Isolated yield of major diastereoisomer (>98:2 dr). 
 
Next, a one-pot Michael addition-lactonisation followed by 
in-situ ring-opening with methanol was trialled (Scheme 2i). In 
this case major anti-diester 10 was obtained in 78% yield in 
>99% ee.25, The use of alternative ring-opening nucleophiles 
was then investigated. Reacting phenylacetic acid 6 with 
trichloromethyl ketone 7 under the standard reaction conditions, 
followed by ring-opening and aminolysis with an excess of 
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isopropylamine gave diamide 11 in 90:10 dr, >99% ee and 67% 
yield (Scheme 2ii). However, the use of secondary amines such 
as pyrrolidine led to a complex mixture of products. 
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Scheme 2 i) Ring-opening and alcoholysis with MeOH; ii) Ring-opening and 
aminolysis with isopropylamine; iii) Ring-opening with allyl alcohol; iv) Sequential 
addition of two nucleophiles. a Isolated yield of major diastereoisomer (>98:2 dr). 
b Determined by 1H NMR spectroscopic analysis of the crude reaction mixture. c 
Determined by chiral HPLC analysis. 
 
Interestingly, use of allyl alcohol as the ring-opening 
nucleophile afforded monoester product 12 in 60% yield, 89:11 
dr and 99% ee, with no substitution of the CCl3 group observed 
(Scheme 2iii). This led to the possibility of forming 
differentially protected diacid derivatives through the sequential 
addition of two nucleophiles. To test this, the reaction between 
phenylacetic acid 6 and trichloromethyl ketone 7 was firstly 
ring-opened with three equivalents of isopropylamine.26 Upon 
the disappearance of the initial dihydropyranone product as 
judged by TLC analysis a large excess of methanol and 
catalytic DMAP (20 mol%) was added. Pleasingly, γ-ester 
amide 13 was isolated in 42% yield over the three one-pot 
reaction steps as a single diastereoisomer in 99% ee (Scheme 
2iv). 
Scope and generality 
With efficient reaction conditions and suitable ring-opening 
protocols in hand, the scope of this Michael addition-
lactonisation process was evaluated through variation of the 
acetic acid component (Table 1). Phenylacetic acid derivatives 
bearing electron-donating (4-OMe), electron-withdrawing (4-
CF3) and halogen (4-F) substituents could be employed in this 
system, affording the corresponding diesters 14-16 with high 
stereocontrol. m-Tolylacetic acid allows formation of diester 17 
in 92:8 dr and >99% ee, whereas o-tolylacetic acid is not 
tolerated (presumably due to steric hindrance) and gave <10% 
conversion into the corresponding diester 18. Heteroaromatic 
substitution was possible through use of 3-thiopheneacetic acid, 
with diester 19 formed in a reduced 81:19 dr but with excellent 
ee for the major anti-diastereoisomer. (E)-4-Methyl and (E)-4-
benzyl alkenoic acids also participate in this process, affording 
diesters 20 and 21 in good yields and with excellent diastereo- 
and enantiocontrol. Unfortunately, the use of 3-phenylpropionic 
acid did not lead to any formation of diester 22 under the 
standard conditions.  
 
Table 1 Scope of 2-aryl and 2-alkenyl acetic acids 
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a Isolated yield of major diastereoisomer (>98:2 dr) b Determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture. c Determined by chiral HPLC 
analysis. 
 
To further examine the scope of the reaction a selection of ,-
unsaturated trichloromethyl ketones was examined (Table 2). 
Within the Michael acceptor, β-aryl groups containing electron-
donating (4-OMe), electron-withdrawing (2-NO2) and halogen 
(4-F) substituents were tolerated, giving the corresponding 
diesters 23-25 in high yields with excellent stereocontrol. A 
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Michael acceptor bearing a heteroaromatic β-2-furyl substituent 
also participates, giving diester 26 with reduced 
diastereoselectivity (80:20 dr), although the major 
diastereoisomer again forms in excellent ee (98%). The 
incorporation of a β-alkyl substituent proved to be more 
challenging, with the reaction of a β-pentyl trichloromethyl 
ketone followed by in situ methanolysis giving a complex 
mixture of products. Further investigation revealed that the 
Michael addition-lactonisation worked well, with 
dihydropyranone 27 isolated in 71% yield albeit in a reduced 
86% ee. Attempts to ring-open isolated dihydropyranone 27 
with either methanol or isopropylamine were also unsuccessful, 
with a complex mixture of products observed in both cases. 
 
Table 2 Scope of α,β-unsaturated trichloromethyl ketones 
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a Isolated yield of major diastereoisomer (>98:2 dr). b Determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture. c Determined by chiral HPLC 
analysis. d Isolated yield of major diastereoisomer (96:4 dr). e Isolated yield of a 
mixture of diastereoisomers. f Steps i) and ii) only. 
 
Proposed mechanism 
The proposed mechanism for this process initiates via N-
acylation of HBTM-2.1 5 with in situ formed mixed anhydride 
28, forming acyl ammonium 29 (Fig. 2). Subsequent 
deprotonation gives the key (Z)-ammonium enolate 30, 
allowing either an no to σ*C-S interaction or favourable 
electrostatic stabilisation between the enolate oxygen and the 
sulfur atom of the isothiourea.27 Stereoselective Michael 
addition to α,β-unsaturated trichloromethyl ketone 31 followed 
by lactonisation gives dihydropyranone 33 and regenerates the 
catalyst. Ring-opening of dihydropyranone 33 with a 
nucleophile generates keto-ester 34, with further alcoholysis of 
the trichloromethyl ketone into diester 35 proceeding at a 
slower rate. 
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Fig. 2 Proposed mechanism for Lewis base catalysed process. 
Conclusions 
In conclusion, the Michael addition-lactonisation of a range of 
2-aryl and 2-alkenylacetic acids and bench-stable ,-
unsaturated trichloromethyl ketones has been demonstrated. 
Upon alcoholysis, the initially formed dihydropyranone 
products are converted into stereodefined diesters, representing 
a formal conjugate addition into an ,-unsaturated ester. Slow 
substitution of the CCl3 group after ring-opening allowed the 
formation of a γ-ester amide through sequential addition of two 
nucleophiles. Further studies within our laboratory are focused 
towards the continued development of isothioureas in catalysis. 
Experimental 
General information 
Anhydrous CH2Cl2 was obtained from an Mbraun SPS-800 
system. Petrol is defined as petroleum ether 40-60 °C. All other 
solvents and commercial reagents were used as supplied 
without further purification unless stated otherwise. 
Room temperature (rt) refers to 20-25 °C. Temperatures of 
0 °C and –78 °C were obtained using ice/water and 
CO2(s)/acetone baths, respectively. Temperatures between 0 °C 
and –60 °C for overnight reactions were obtained using an 
immersion cooler (HAAKE EK 90).  
Analytical thin layer chromatography was performed on 
pre-coated aluminium plates (Kieselgel 60 F254 silica). TLC 
visualisation was carried out with ultraviolet light (254 nm), 
followed by staining with a 1% aqueous KMnO4 solution and 
heating. Flash column chromatography was performed on 
Kieselgel 60 silica in the solvent system stated. 
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Melting points were recorded on an Electrothermal 9100 
apparatus, dec refers to decomposition, sub refers to 
sublimation.   
Optical rotations were measured on a Perkin Elmer 
Precisely/Model-341 polarimeter operating at the sodium D line 
with a 100 mm path cell at 20 °C. 
HPLC analyses were obtained on a Shimadzu HPLC 
consisting of a DGU-20A5 degasser, LC-20AT liquid 
chromatograph, SIL-20AHT autosampler, CMB-20A 
communications bus module, SPD-M20A diode array detector 
and a CTO-20A column oven which allowed the temperature to 
be set from 25-40 °C. Separation was achieved using Chiralcel 
OD-H and OJ-H columns or Chiralpak AD-H, AS-H, IA, and 
IB columns. 
Infrared spectra (νmax) were recorded on a Shimadzu 
IRAffinity-1 Fourier transform IR spectrophotometer as thin 
films using Pike MIRacle ATR accessory. Analysis was carried 
out using Shimadzu IRsolution v1.50 and only characteristic 
peaks are reported. 
1H, 13C{1H}, and 19F {1H}NMR spectra were acquired on 
either a Bruker Avance 300 {H (300 MHz), C (75 MHz), F 
(282 MHz)}, a Bruker Avance II 400 {H (400 MHz), C (100 
MHz), F (376 MHz)} or a Bruker Ultrashield 500 {H (500 
MHz), C (125 MHz), F (471 MHz)} spectrometer at ambient 
temperature in the deuterated solvent stated. Chemical shifts, , 
are quoted in parts per million (ppm) and are referenced to the 
residual solvent peak. Coupling constants, J, are quoted in 
Hertz (Hz) to the nearest 0.1 Hz. The following abbreviations 
are used: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; 
and br, broad. 
Mass spectrometry (m/z) data were acquired by electrospray 
ionisation (ESI), electron impact (EI), chemical ionisation (CI), 
atmospheric solids analysis probe (ASAP), atmospheric 
pressure chemical ionisation (APCI) or nanospray ionisation 
(NSI) at the EPSRC National Mass Spectrometry Service 
Centre, Swansea. 
General procedure A: synthesis of trichloromethyl carbinols 
Following a literature procedure,19c trichloroacetic acid (1.5 eq) 
and sodium trichloroacetate (1.5 eq) were added to a solution of 
the appropriate aldehyde (1 eq) in DMF at 0 °C. The reaction 
mixture was stirred in the ice/water bath and allowed to warm 
slowly to rt over 16 h before being diluted with water and 
extracted with EtOAc (× 3). The combined organic fraction was 
washed with water (× 3), sat. aq. NaHCO3, dried (MgSO4), 
filtered and concentrated under reduced pressure to give the 
crude product, which was purified by flash silica column 
chromatography. 
General procedure B: synthesis of α,β-unsaturated 
trichloromethyl ketones 
Following a literature procedure,20 a solution of DMSO (8 eq) 
in CH2Cl2 was added dropwise to a solution of oxalyl chloride 
(4 eq) in CH2Cl2 at −60 °C followed by stirring for 2 min at 
−60 °C. A solution of the appropriate alcohol (1 eq) in CH2Cl2 
was added dropwise followed by stirring for 15 min at −60 °C. 
Et3N (20 eq) was added dropwise and the reaction mixture was 
stirred and allowed to warm to rt. The reaction mixture was 
quenched with 2 M HCl and extracted with CH2Cl2 (× 3). The 
combined organic fraction was dried (MgSO4), filtered and 
concentrated under reduced pressure to give the crude product, 
which was purified by flash silica column chromatography. 
General procedure C: intermolecular Michael addition-
lactonisation followed by in situ ring-opening 
i-Pr2NEt (2.25 eq) and pivaloyl chloride (2.25 eq) were added 
to a solution of the appropriate carboxylic acid (1.5 eq) in 
CH2Cl2 (to give 0.1 M trichloromethyl ketone) at rt and the 
reaction mixture was stirred for 5 min before cooling to −78 °C. 
HBTM-2.1 (2S,3R)-5  (5 mol%), the appropriate α,β-
unsaturated trichloromethyl ketone (1 eq) and i-Pr2NEt (1.5 eq) 
were added in succession and the reaction mixture was stirred 
at −78 °C for 16 h. The appropriate nucleophile (excess) and 
DMAP (20 mol%) were added and the reaction mixture was 
stirred at rt for 24 h. The reaction mixture was diluted with 
CH2Cl2 and washed with 1 M HCl and brine. The organic layer 
was dried (MgSO4), filtered and concentrated under reduced 
pressure to give the crude product, which was purified by flash 
silica column chromatography. 
Authentic racemic samples were prepared in an analogous 
fashion using racemic isothiourea catalyst (rac)-HBTM-2.1 5. 
Preparation of trichloromethyl carbinols 
(E)-1,1,1-Trichloro-4-phenylbut-3-en-2-ol 36. Following 
general procedure A, cinnamaldehyde (5.03 mL, 40.0 mmol), 
DMF (30 mL), trichloroacetic acid (9.80 g, 60.0 mmol) and 
sodium trichloroacetate (11.1 g, 60.0 mmol) gave, after column 
chromatography (90:10 Petrol:Et2O, Rf = 0.20), the title 
compound 36 (4.78 g, 48%) as an orange oil with spectroscopic 
data in accordance with the literature.28 1H NMR (400 MHz, 
CDCl3) δH: 2.92 (1H, d, J 5.6, OH), 4.75−4.80 (1H, m, C(2)H), 
6.37 (1H, dd, J 15.9, 6.1, C(3)H), 6.91 (1H, d, J 15.9, C(4)H), 
7.28−7.39 (3H, m, ArC(3,5)H and ArC(4)H), 7.43−7.47 (2H, 
m, ArC(2,6)H). 
(E)-1,1,1-Trichloro-4-(4-methoxyphenyl)but-3-en-2-ol 
37. Following general procedure A, 4-methoxycinnamaldehyde 
(6.49 mL, 40.0 mmol), DMF (30 mL), trichloroacetic acid (9.80 
g, 60.0 mmol) and sodium trichloroacetate (11.1 g, 60.0 mmol) 
gave, after column chromatography (80:20 Petrol:Et2O, Rf = 
0.20), the title compound 37 (9.04 g, 80%) as a white solid; mp 
66−68 °C; νmax (ATR) 3356 (O-H), 2967 (C-H), 1653, 1605, 
1514; 1H NMR (500 MHz, CDCl3) δH: 2.98 (1H, d, J 5.8, OH), 
3.82 (3H, s, OCH3), 4.74 (1H, app t, J 6.1, C(2)H), 6.22 (1H, 
dd, J 15.9, 6.3, C(3)H), 6.83 (1H, d, J 15.9, C(4)H), 6.87−6.91 
(2H, m, ArC(3,5)H), 7.37−7.39 (2H, m, ArC(2,6)H); 13C{1H} 
NMR (125 MHz, CDCl3) δC: 55.5 (OCH3), 83.7 (C(2)), 103.1 
(C(1)), 114.2 (ArC(3,5)), 120.4 (C(3)), 128.4 (ArC(2,6)), 128.5 
(ArC(1)), 136.5 (C(4)), 160.1 (ArC(4)); HRMS (APCI+) 
C11H12
35Cl3O2 [M+H]
+, found 280.9894, requires 280.9897 
(−1.2 ppm). 
(E)-1,1,1-Trichloro-4-(2-nitrophenyl)but-3-en-2-ol 38. 
Following general procedure A, 2-nitrocinnamaldehyde (7.09 mL, 
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40.0 mmol), DMF (100 mL), trichloroacetic acid (9.80 g, 60.0 
mmol) and sodium trichloroacetate (11.1 g, 60.0 mmol) gave, after 
column chromatography (70:30 Petrol:Et2O, Rf = 0.30), the title 
compound 38 (3.12 g, 26%) as a white solid; mp 114−116 °C; νmax 
(ATR) 3291 (O-H), 2973 (C-H), 1607, 1518; 1H NMR (300 MHz, 
DMSO-d6) δH: 4.83 (1H, app t, J 5.8, C(2)H), 6.44 (1H, dd, J 15.6, 
5.9, C(3)H), 7.15−7.23 (2H, m, C(4)H and ArCH), 7.56−7.60 (1H, 
m, ArCH), 7.71−7.76 (2H, m, ArCH), 7.99 (1H, d, J 8.2, ArC(3)H); 
13C{1H} NMR (75 MHz, DMSO-d6) δC: 81.5 (C(2)), 103.5 (C(1)), 
124.3 (ArC(3)), 128.6 (ArC), 129.3 (ArC), 129.8 (C(4)), 130.0 
(C(3)), 130.6 (ArC(1)), 133.6 (ArC), 147.8 (ArC(2)); HRMS 
(APCI+) C10H12
35Cl3NO3 [M+NH4]
+, found 312.9907, requires 
312.9908 (−0.3 ppm). 
(E)-1,1,1-Trichloro-4-(4-fluorophenyl)but-3-en-2-ol 39. 
Following general procedure A, 4-fluorocinnamaldehyde (5.00 g, 
33.3 mmol), DMF (30 mL), trichloroacetic acid (8.17 g, 50.0 mmol) 
and sodium trichloroacetate (9.27 g, 50.0 mmol) gave, after column 
chromatography (85:15 Petrol:Et2O, Rf = 0.25), the title compound 
39 (4.71 g, 52%) as an orange solid with spectroscopic data in 
accordance with the literature.19a mp 66−64 °C; {Lit.19a mp 60−62 
°C}; 1H NMR (400 MHz, CDCl3) δH: 2.92 (1H, d, J 5.7, OH), 4.76 
(1H, td, J 5.9, 1.3, C(2)H), 6.29 (1H, ddd, J 15.9, 6.1, 0.6, C(3)H), 
6.87 (1H, d, J 15.9, C(4)H), 7.01−7.08 (2H, m, ArC(3,5)H), 
7.38−7.46 (2H, m, ArC(2,6)H); 19F{1H} NMR (376 MHz, CDCl3) 
δF: −113.18 (ArC(4)F). 
(E)-1,1,1-Trichloro-4-(furan-2-yl)but-3-en-2-ol 40. Following 
general procedure A, 3-(furan-2-yl)acrylaldehyde (5.00 g, 40.9 
mmol), DMF (30 mL), trichloroacetic acid (10.1 g, 61.4 mmol) and 
sodium trichloroacetate (11.4 g, 61.4 mmol) gave, after column 
chromatography (85:15 Petrol:Et2O, Rf = 0.25), the title compound 
40 (4.00 g, 40%) as a yellow oil; 1H NMR (400 MHz, CDCl3) δH: 
2.89 (1H, d, J 5.9, OH), 4.75 (1H, td, J 5.9, 1.3, C(2)H), 6.33 (1H, 
dd, J 15.8, 5.8, C(3)H), 6.37 (1H, d, J 3.3, ArC(3)H), 6.41 (1H, dd, J 
3.3, 1.8, ArC(4)H), 6.72 (1H, dd, J 15.8, 1.3, C(4)H), 7.40 (1H, d, J 
1.6, ArC(5)H). The title compound was carried forward immediately 
without further characterisation due to instability. 
(E)-1,1,1-Trichloronon-3-en-2-ol 41. Following general 
procedure A, (E)-oct-2-enal (5.00 mL, 39.6 mmol), DMF (30 mL), 
trichloroacetic acid (9.76 g, 59.4 mmol) and sodium trichloroacetate 
(11.1 g, 59.4 mmol) gave, after column chromatography (95:5 
Petrol:Et2O, Rf = 0.20), the title compound 41 (4.71 g, 48%) as a 
yellow oil with spectroscopic data in accordance with the literature.29 
1H NMR (400 MHz, CDCl3) δH: 0.81−0.95 (3H, m, CH3), 1.24−1.48 
(6H, m, 3 × CH2), 2.08−2.17 (2H, m, C(5)H2), 2.72 (1H, d, J 5.9, 
OH), 4.51−4.56 (1H, m, C(2)H), 5.65 (1H, ddt, J 15.5, 6.5, 1.5, 
C(3)H), 6.02 (1H, dtd, J 15.5, 6.9, 1.0, C(4)H). 
Preparation of α,β-unsaturated trichloromethyl ketones 
(E)-1,1,1-Trichloro-4-phenylbut-3-en-2-one 7. Following 
general procedure B, oxalyl chloride (6.43 mL, 76.0 mmol) in 
CH2Cl2 (300 mL), DMSO (10.8 mL, 152 mmol) in CH2Cl2 (35 mL), 
(E)-1,1,1-trichloro-4-phenylbut-3-en-2-ol 36 (4.78 g, 19.0 mmol) in 
CH2Cl2
 (20 mL) and Et3N (53.0 mL, 380 mmol) gave, after column 
chromatography (95:5 Petrol:Et2O, Rf = 0.30), the title compound 7 
(4.41 g, 93%) as a yellow solid; mp 56−58 °C; νmax (ATR) 3059, 
3030 (C-H), 1707 (C=O); 1H NMR (500 MHz, CDCl3) δH: 7.35 (1H, 
d, J 15.7, C(3)H), 7.43−7.49 (3H, m, ArC(3,5)H and ArC(4)H), 
7.65−7.66 (2H, m, ArC(2,6)H), 8.01 (1H, d, J 15.7, C(4)H); 13C{1H} 
NMR (125 MHz, CDCl3) δC: 96.6 (C(1)), 115.9 (C(3)), 129.1 (ArC), 
129.3 (ArC), 131.9 (ArC(4)), 133.9 (ArC(1)), 149.8 (C(4)), 180.2 
(C(2)); HRMS (APCI+) C10H8
35Cl3O [M+H]
+, found 248.9634, 
requires 248.9635 (−0.5 ppm). 
(E)-1,1,1-Trichloro-4-(4-methoxyphenyl)but-3-en-2-one 42. 
Following general procedure B, oxalyl chloride (6.43 mL, 76.0 
mmol) in CH2Cl2 (300 mL), DMSO (10.8 mL, 152 mmol) in CH2Cl2 
(35 mL), (E)-1,1,1-trichloro-4-(4-methoxyphenyl)but-3-en-2-ol 37 
(5.35 g, 19.0 mmol) in CH2Cl2
 (20 mL) and Et3N (53.0 mL, 380 
mmol) gave, after column chromatography (90:10 Petrol:Et2O, Rf = 
0.20), the title compound 42 (4.63 g, 87%) as a yellow solid; mp 
98−100 °C; νmax (ATR) 3013, 2835 (C-H), 1699 (C=O), 1587 1562, 
1508; 1H NMR (500 MHz, CDCl3) δH: 3.87 (3H, s, OCH3), 6.95 
(2H, d, J 8.7, ArC(3,5)H), 7.21 (1H, d, J 15.5, C(3)H), 7.60−7.63 
(2H, m, ArC(2,6)H), 7.97 (1H, d, J 15.5, C(4)H); 13C{1H} NMR 
(125 MHz, CDCl3) δC: 55.6 (OCH3), 96.8 (C(1)), 113.2 (C(3)), 114.7 
(ArC(3,5)), 126.7 (ArC(1)), 131.1 (ArC(2,6)), 149.7 (C(4)), 162.8 
(ArC(4)), 180.3 (C(2)); HRMS (APCI+) C11H10
35Cl3O2 [M+H]
+, 
found 278.9747, requires 278.9741 (+2.2 ppm). 
(E)-1,1,1-Trichloro-4-(2-nitrophenyl)but-3-en-2-one 43. 
Following general procedure B, oxalyl chloride (2.85 mL, 33.6 
mmol) in CH2Cl2 (150 mL), DMSO (4.78 mL, 67.2 mmol) in 
CH2Cl2 (20 mL), (E)-1,1,1-trichloro-4-(2-nitrophenyl)but-3-en-2-ol 
38 (2.49 g, 8.40 mmol) in CH2Cl2
 (100 mL) and Et3N (23.4 mL, 168 
mmol) gave, after column chromatography (75:25 Petrol:Et2O, Rf = 
0.30), the title compound 43 (2.13 g, 86%) as a white solid; mp 56-
58 °C; νmax (ATR) 3103, 2857 (C-H), 1715 (C=O), 1605, 1570, 
1520; 1H NMR (400 MHz, CDCl3) δH: 7.24 (1H, d, J 15.5, C(3)H), 
7.60−7.66 (1H, m, ArCH), 7.70−7.75 (2H, m, ArCH), 8.10−8.12 
(1H, m, ArC(3)H), 8.43 (1H, d, J 15.5, C(4)H); 13C{1H} NMR (100 
MHz, CDCl3) δC: 96.1 (C(1)), 120.7 (C(3)), 125.3 (ArC(3)), 129.5 
(ArC), 130.1 (ArC(1)), 131.5 (ArC), 133.9 (ArC), 144.9 (C(4)), 
148.6 (ArC(2)), 179.1 (C(2)); HRMS (APCI+) C10H7
35Cl3NO3 
[M+H]+, found 293.9491, requires 293.9486 (+1.7 ppm). 
(E)-1,1,1-Trichloro-4-(4-fluorophenyl)but-3-en-2-one 44. 
Following general procedure B, oxalyl chloride (3.17 mL, 37.4 
mmol) in CH2Cl2 (150 mL), DMSO (5.32 mL, 74.7 mmol) in 
CH2Cl2 (20 mL), (E)-1,1,1-trichloro-4-(4-fluorophenyl)but-3-en-2-ol 
39 (2.52 g, 9.34 mmol) in CH2Cl2
 (10 mL) and Et3N (26.1 mL, 187 
mmol) gave, after column chromatography (95:5 Petrol:Et2O, Rf = 
0.25), the title compound 44 (2.38 g, 95%) as a white solid with 
spectroscopic data in accordance with the literature.19a mp 59−61 °C; 
{Lit.19a mp 58−60 °C}; 1H NMR (500 MHz, CDCl3) δH: 7.10−7.18 
(2H, m, ArC(3,5)H), 7.26 (1H, d, J 15.6, C(3)H), 7.62−7.70 (2H, m, 
ArC(2,6)H), 7.97 (1H, d, J 15.6, C(4)H); 19F{1H} NMR (471 MHz, 
CDCl3) δF: −106.65 (ArC(4)F). 
(E)-1,1,1-Trichloro-4-(furan-2-yl)but-3-en-2-one 45. 
Following general procedure B, oxalyl chloride (5.62 mL, 66.3 
mmol) in CH2Cl2 (300 mL), DMSO (9.43 mL, 133 mmol) in CH2Cl2 
(30 mL), (E)-1,1,1-trichloro-4-(furan-2-yl)but-3-en-2-ol 40 (4.00 g, 
16.6 mmol) in CH2Cl2
 (20 mL) and Et3N (46.3 mL, 331 mmol) gave, 
after column chromatography (90:10 Petrol:Et2O, Rf = 0.35), the title 
compound 45 (1.00 g, 25%) as a light yellow solid with 
spectroscopic data in accordance with the literature.19b mp 40−42 °C; 
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{Lit.19b mp 42−44 °C}; 1H NMR (400 MHz, CDCl3) δH: 6.56 (1H, 
dd, J 3.5, 1.8, ArC(4)H), 6.84 (1H, d, J 3.6, ArC(3)H), 7.21 (1H, d, J 
15.3, C(3)H), 7.57−7.60 (1H, m, ArC(5)H), 7.73 (1H, d, J 15.3, 
C(4)H). 
(E)-1,1,1-Trichloronon-3-en-2-one 46. Following general 
procedure B, oxalyl chloride (6.51 mL, 76.7 mmol) in CH2Cl2 (300 
mL), DMSO (10.9 mL, 154 mmol) in CH2Cl2 (30 mL), (E)-1,1,1-
trichloronon-3-en-2-ol 41 (4.71 g, 19.2 mmol) in CH2Cl2
 (200 mL) 
and Et3N (53.7 mL, 384 mmol) gave, after column chromatography 
(97:3 Petrol:Et2O, Rf = 0.35), the title compound 46 (4.11 g, 88%) as 
a yellow oil; νmax (ATR) 2928 (C-H), 1722 (C=O), 1625 (C=C); 
1H 
NMR (400 MHz, CDCl3) δH: 0.87−0.93 (3H, m, CH3), 1.28−1.38 
(4H, m, 2 CH2), 1.48−1.56 (2H, m, C(6)H2), 2.34 (2H, app qd, J 7.2, 
1.6, C(5)H2), 6.73 (1H, dt, J 15.3, 1.6, C(3)H), 7.34 (1H, dt, J 15.4, 
7.0, C(4)H); 13C{1H} NMR (100 MHz, CDCl3) δC: 14.1 (CH3), 22.5 
(CH2), 27.6 (C(6)H2), 31.5 (CH2), 33.2 (C(5)H2), 96.5 (C(1)), 119.7 
(C(3)), 156.0 (C(4)), 179.8 (C(2)); HRMS (APCI+) C9H14
35Cl3O 
[M+H]+, found 243.0104, requires 243.0105 (−0.3 ppm). 
Preparation of products 
(3R,4R)-3,4-Diphenyl-6-(trichloromethyl)-3,4-dihydro-2H-
pyran-2-one 8. Phenyl acetic acid (164 mg, 1.2 mmol), i-Pr2NEt 
(312 μL, 1.8 mmol), pivaloyl chloride (222 μL, 1.8 mmol), in 
CH2Cl2 (8 mL), followed by HBTM-2.1 (2S,3R)-5 (12 mg, 0.04 
mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 7 (200 mg, 0.8 
mmol), i-Pr2NEt (208 μL, 1.2 mmol) gave crude product (87:13 dr 
anti:syn). Column chromatography (92.5:7.5 Petrol:EtOAc, Rf = 
0.25) gave title compound 8 (244 mg, 82%) as a white solid (87:13 
dr anti:syn) mp 86−88 °C; νmax (ATR) 1003, 1119, 1454, 1773, 
2031, 3063; 
20
D
][  −0.986 (c 0.5 CHCl3); Data for major anti 
diastereoisomer: 1H NMR (500 MHz, CDCl3) δH 3.97−4.01 (1H, m, 
C(4)H), 4.05−4.07 (1H, m, C(3)H), 6.37 (1H, d, J 4.1, C(5)H), 7.09 
(2H, d, J 6.7, ArH), 7.16 (2H, d, J 6.4, ArH), 7.27−7.35 (6H, m, 
ArH); 13C{1H} NMR (125 MHz, CDCl3) δC 45.2 (C(3)H), 52.6 
(C(4)H), 90.1 (CCl3), 107.8 (C(5)H), 127.5 (ArCH), 128.1 (ArCH), 
128.2 (ArCH), 128.3 (ArCH), 129.0 (ArCH), 129.3 (ArCH), 135.4 
(ArC), 139.4 (ArC), 149.0 (ArC), 166.4 (C(2)); Data for minor syn 
diastereoisomer; 1H NMR (500 MHz, CDCl3) δH 3.73 (1H, br s, 
C(4)H), 4.28 (1H, d, J 7.0, C(3)H), 6.54 (1H, d, J 6.0, C(5)H), 6.76 
(2H, d, J 6.8, ArH), 6.81 (2H, d, J 6.9, ArH), 7.27−7.35 (6H, m, 
ArH); 13C{1H} NMR (125 MHz, CDCl3) δC 44.6 (C(3)H), 50.9 
(C(4)H), 91.2 (CCl3), 108.6 (C(5)H), 127.2 (ArCH), 128.0 (ArCH), 
128.4 (ArCH), 128.7 (ArCH), 128.9 (ArCH), 128.9 (ArC), 129.6 
(ArC), 129.8 (ArCH), 149.7 (ArC), 166.1 (C(2)); HRMS (NSI+) 
C18H13
35Cl3O2Na [M+Na]
+, found 388.9880, requires 388.9873 
(+1.7 ppm). 
HPLC or GC analysis not achieved in our hands, ee determined 
through derivatisation into diester 10. 
6-(Dichloromethyl)-3,4-diphenyl-2H-pyran-2-one 9. MeOH (9 
μL) in CH2Cl2 (2.4 mL) was added to a solution of lactone 8 (81 mg, 
0.22 mmol) and DMAP (5 mg, 0.04 mmol) in CH2Cl2 (2 mL) at rt 
and the reaction stirred for 6 h. Column chromatography (85:15 
Petrol: EtOAc, Rf = 0.25) gave the title compound 9 (47 mg, 65%) as 
a white solid; mp 196−197 oC; νmax (ATR) 1348, 1647, 1709, 3001, 
3030, 3090; 1H NMR (500 MHz) δH: 6.40 (1H, s, CHCl2), 6.73 (1H, 
s, C(5)H), 7.10−7.12 (2H, m, ArH), 7.16 (2H, m, ArH), 7.23−7.30 
(6H, m, ArH); 13C{1H} NMR (125 MHz) δC: 65.2 (CHCl2), 107.2 
(C(5)H), 126.2 (C(3)), 128.3 (ArCH), 128.4 (ArCH), 128.7 (ArCH), 
128.8 (ArCH), 129.3 (ArCH), 130.8 (ArCH), 133.1 (ArC(4)), 136.8 
(C(3)ArC(1)), 151.2 (C(4)ArC(1)), 155.2 (C(2)), 161.2 (C(6)); 
HRMS (NSI+) C18H13
35Cl2O2 [M+H]
+, found 331.0296, requires 
331.0287 (+2.7 ppm). 
Dimethyl (2R,3R)-2,3-diphenylpentanedioate 10. Method A:  
MeOH (6 mL) was added to a solution of lactone 8 (140 mg, 0.38 
mmol) and DMAP (9 mg, 0.076 mmol) in CH2Cl2 (6 mL) and 
reaction stirred at rt for 16 h. Concentration of reaction under 
reduced pressure gave crude product (87:13 dr anti:syn). Column 
chromatography (80:20 Petrol:Et2O, Rf = 0.25) gave the title 
compound 9 (74 mg, 62%) as a white solid (>98:2 dr anti:syn). All 
data in accordance to that provided for method B below. 
Method B: Following general procedure C, phenylacetic acid (81.6 
mg, 0.60 mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl chloride 
(111 μL, 0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 
mg, 0.02 mmol, 5 mol%), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-
one 7 (99.8  mg, 0.40 mmol), i-Pr2NEt (104 μL, 0.60 mmol), MeOH 
(4 mL) and DMAP (9.76 mg, 0.08 mmol) gave the crude product 
(89:11 dr anti:syn). Column chromatography (80:20 Petrol:Et2O, Rf 
= 0.25) gave the title compound 10 (97.0 mg, 78%) as a white solid 
(>98:2 dr anti:syn) with spectroscopic data in accordance with the 
literature.13 mp 68−70 °C; {Lit.13 mp 62−63 °C}; 
20
D
][  −116.6 (c 
1.0 CHCl3); {Lit.
13 
20
D
][  −125.7 (c 0.3 CHCl3) for 97% ee (2R,3R) 
stereoisomer}; Chiral HPLC analysis, Chiralpak AD-H (95:5 
hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 °C) tR(2S,3S): 10.2 
min, tR(2R,3R): 11.7 min, >99% ee; 
1H NMR (500 MHz, CDCl3) δH: 
2.78−2.86 (2H, m, C(4)HH and C(4)HH), 3.51 (3H, s, C(5)O2CH3), 
3.69 (3H, s, C(1)O2CH3), 3.84−3.90 (2H, m, C(2)H and C(3)H), 
7.00−7.02 (2H, m, ArCH), 7.03−7.06 (1H, m, ArCH), 7.08−7.14 
(7H, m, ArCH). 
(2R,3R)-N1,N5-Diisopropyl-2,3-diphenylpentanediamide 11. 
Following general procedure C, phenylacetic acid (81.6 mg, 0.60 
mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl chloride (111 μL, 
0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 
mmol, 5 mol%), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 7 (99.8  
mg, 0.40 mmol), i-Pr2NEt (104 μL, 0.60 mmol), isopropylamine (4 
mL) and DMAP (9.76 mg, 0.08 mmol) gave the crude product 
(90:10 dr anti:syn). Column chromatography (EtOAc, Rf = 0.35) 
gave the title compound 11 (100 mg, 67%) as a white solid (>98:2 dr 
anti:syn) with spectroscopic data in accordance with the literature.13 
mp 250−252 °C; {Lit.13 mp 264−266 °C}; 
20
D
][  −26.0 (c 0.1 
CHCl3); {Lit.
13 
20
D
][  −20.0 (c 0.1 CHCl3) for 99% ee (2R,3R) 
stereoisomer}; Chiral HPLC analysis, Chiralpak AD-H (95:5 
hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 °C) tR(2S,3S): 7.1 min, 
tR(2R,3R): 23.5 min, >99% ee; 
1H NMR (400 MHz, CD3OD) δH: 
0.72 (3H, d, J 6.6, CH3), 0.94 (3H, d, J 6.6, CH3), 1.03 (3H, d, J 6.6, 
CH3), 1.18 (3H, d, J 6.6, CH3), 2.50 (1H, dd, J 13.3, 11.3, C(4)HH), 
2.64 (1H, dd, J 13.3, 4.1, C(4)HH), 3.64−3.73 (2H, m, C(2)H and 
CH(CH3)2), 3.83 (1H, td, J 11.3, 4.1, C(3)H), 3.95 (1H, heptet, J 6.5, 
CH(CH3)2), 6.97−7.10 (8H, m, ArCH), 7.21−7.24 (2H, m, ArCH). 
Allyl (2R,3R)-6,6,6-trichloro-5-oxo-2,3-diphenylhexanoate 12. 
Following general procedure C, phenylacetic acid (81.6 mg, 0.60 
mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl chloride (111 μL, 
0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 
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mmol, 5 mol%), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 7 (99.8  
mg, 0.40 mmol), i-Pr2NEt (104 μL, 0.60 mmol), allyl alcohol (4 mL) 
and DMAP (9.76 mg, 0.08 mmol) gave the crude product (89:11 dr 
anti:syn). Column chromatography (95:5 Petrol:Et2O, Rf = 0.25) 
gave the title compound 12 (102 mg, 60%) as a white solid (>98:2 dr 
anti:syn). mp 90−92 °C; 
20
D
][  −50.8 (c 0.25 CH2Cl2); Chiral HPLC 
analysis, Chiralpak AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 
211 nm, 30 °C) tR(2S,3S): 8.1 min, tR(2R,3R): 9.5 min, 99% ee; νmax 
(ATR) 3030, 2945 (C-H), 1746 (C=O), 1726 (C=O); 1H NMR (500 
MHz, CDCl3) δH: 3.35 (1H, dd, J 17.7, 3.1, C(4)HH), 3.67 (1H, dd, J 
17.7, 10.2, C(4)HH), 3.96 (1H, d, J 10.9, C(2)H), 4.02 (1H, td, J 
10.5, 3.1, C(3)H), 4.56−4.67 (2H, m, CO2CHH and CO2CHH), 
5.18−5.23 (2H, m, =CHH and =CHH), 5.85 (1H, app ddt, J 17.1, 
10.5, 5.7, =CH), 7.03-7.16 (10H, m, ArH); 13C{1H} NMR (125 
MHz, CDCl3) δC: 38.8 (C(4)), 45.0 (C(3)), 57.1 (C(2)), 65.8 
(CO2CH2), 118.8 (CH=CH2), 127.1 (ArC), 127.6 (ArC), 128.3 
(ArC), 128.5 (ArC), 128.5 (ArC), 128.6 (ArC), 131.8 (CH=CH2), 
136.4 (ArC), 139.3 (ArC), 172.6 (C(1)), 188.1 (C(5)); HRMS (NSI+) 
C21H20
35Cl3O3 [M+H]
+, found 425.0474, requires 425.0473 (+0.3 
ppm). 
Methyl (3R,4R)-5-(isopropylamino)-5-oxo-3,4-diphenylpent-
anoate 13. Phenylacetic acid (81.7 mg, 0.60 mmol) was dissolved in 
CH2Cl2 (4 mL) before i-Pr2NEt (156 μL, 0.90 mmol) and pivaloyl 
chloride (111 μL, 0.90 mmol) were added. After stirring at rt for 5 
min the solution was cooled to −78 °C and HBTM-2.1 (2S,3R)-5 
(6.16 mg, 0.02 mmol, 5 mol%), (E)-1,1,1-trichloro-4-phenylbut-3-
en-2-one 7 (99.8  mg, 0.40 mmol), i-Pr2NEt (104 μL, 0.60 mmol) 
were added in succession. The reaction mixture was stirred at −78 
°C for 16 h before i-PrNH2 (111 μL, 1.30 mmol) was added and the 
mixture warmed to rt. Upon consumption of the intermediate 
dihydropyranone by TLC analysis, MeOH (4 mL) and DMAP (9.8 
mg, 0.08 mmol) were added and the reaction stirred overnight at rt. 
The solution was diluted with CH2Cl2 and washed with 1M HCl (2 × 
20 mL) and brine (2 × 20 mL) before being dried over MgSO4, 
filtered and concentrated under reduced pressure. The crude product 
was purified by column chromatography (hexane to 60:40 
hexane:EtOAc, Rf = 0.21). The resulting solid was further purified 
by recrystallisation from Et2O and hexane to give the title compound 
13 (57 mg, 42%) as a white solid (>98:2 dr anti:syn). mp 110−112 
°C; 
20
D
][  −84.3 (c 0.4 CHCl3); Chiral HPLC analysis, Chiralpak 
AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 °C) 
tR(2S,3S): 23.6 min, tR(3R,4R): 26.7 min, 99% ee; νmax (ATR) 3378, 
3308, 2974, 1740, 1722, 1659, 1636, 1533, 1452, 1369; 1H NMR 
(300 MHz, CDCl3) δH: 1.02 (3H, d, J 6.54, NCH(CH3)2), 1.12 (3H, 
d, J 6.54, NCH(CH3)2), 2.80 (1H, dd, J 15.4, 9.3, C(2)HH), 2.92 
(1H, dd, J 15.4, 4.5, C(2)HH), 3.50 (3H, s, OCH3), 3.58 (1H, d, J 
10.3, C(4)H), 3.89 (1H, ddd, J 10.3, 9.8, 4.5, C(3)H), 4.00−4.11 (1H, 
m, NCH(CH3)2), 5.42 (1H, br d, J 7.6, NH), 7.00−7.16 (10H, m, 
ArCH); 13C{1H} NMR (100 MHz, CDCl3) δC: 22.6 (NCH(CH3)2), 
22.9 (NCH(CH3)2), 38.9 (C(2)H2), 41.7 (C(3)H), 45.5 (NCH), 51.6 
(OCH3), 58.4 (C(4)H), 126.7 (ArCH), 127.1 (ArCH), 128.2 (ArCH), 
128.3 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 138.0 (ArC), 140.9 
(ArC), 171.3 (C(5)), 172.6 (C(1); HRMS (NSI+) C21H26NO3 
[M+H]+, found 340.1909, requires 340.1907 (+0.5 ppm). 
Dimethyl (2R,3R)-2-(4-methoxyphenyl)-3-phenylpentanedi-
oate 14. Following general procedure C, 4-methoxyphenylacetic 
acid (99.7 mg, 0.60 mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl 
chloride (111 μL, 0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 
(2S,3R)-5 (6.16 mg, 0.02 mmol, 5 mol%), (E)-1,1,1-trichloro-4-
phenylbut-3-en-2-one 7 (99.8 mg, 0.40 mmol), i-Pr2NEt (104 μL, 
0.60 mmol), MeOH (4 mL) and DMAP (9.76 mg, 0.08 mmol) gave 
the crude product (92:8 dr anti:syn). Column chromatography (75:25 
Petrol:Et2O, Rf = 0.25) gave the title compound 14 (105 mg, 77%) as 
a white solid (>98:2 dr anti:syn) with spectroscopic data in 
accordance with the literature.13 mp 96−98 °C; {Lit.13 mp 99−101 
°C}; 
20
D
][  −126.8 (c 0.5 CHCl3); {Lit.
13 
20
D
][  −135.1 (c 0.2 
CHCl3) for >99% ee (2R,3R) stereoisomer}; Chiral HPLC analysis, 
Chiralpak AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 
°C) tR(2S,3S): 16.7 min, tR(2R,3R): 22.9 min, >99% ee; 
1H NMR 
(400 MHz, CDCl3) δH: 2.73−2.82 (2H, m, C(4)HH and C(4)HH), 
3.51 (3H, s, C(5)O2CH3), 3.69 (3H, s, CH3), 3.70 (3H, s, CH3), 
3.78−3.83 (2H, m, C(2)H and C(3)H), 6.64−6.68 (2H, m, 
C(2)ArC(3,5)H), 6.99−7.14 (7H, m, ArCH). 
Dimethyl (2R,3R)-3-phenyl-2-(4-(trifluoromethyl)phenyl)-
pentanedioate 15. Following general procedure C, 2-(4-
(trifluoromethyl)phenyl)acetic acid (122.5 mg, 0.60 mmol), i-Pr2NEt 
(156 μL, 0.90 mmol), pivaloyl chloride (111 μL, 0.90 mmol) in 
CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 mmol, 5 
mol%), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 7 (99.8 mg, 0.40 
mmol), i-Pr2NEt (104 μL, 0.60 mmol), MeOH (4 mL) and DMAP 
(9.76 mg, 0.08 mmol) gave the crude product (85:15 dr anti:syn). 
Column chromatography (90:10 Hexane:EtOAc, Rf = 0.15) gave the 
title compound 15 (99.0 mg, 65%) as a white solid (>98:2 dr 
anti:syn). mp 96−98 °C; 
20
D
][  −84.8 (c 0.8 CHCl3); Chiral HPLC 
analysis, Chiralpak AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 
211 nm, 30 °C) tR(2S,3S): 11.4 min, tR(2R,3R): 12.9 min, 91% ee; 
νmax (ATR) 2954, 1732, 1439, 1325, 1246, 1111; 
1H NMR (400 
MHz, CDCl3) δH: 2.79−2.82 (2H, m, C(4)HH and C(4)HH), 3.52 
(3H, s, C(5)O2CH3), 3.71 (3H, s, C(1)O2CH3), 3.83−3.95 (2H, m, 
C(2)H and C(3)H), 6.97−7.00 (2H, m, C(3)ArC(2,6)H), 7.03−7.15 
(3H, m, C(3)ArC(3,4,5)H), 7.25 (2H, d, J 8.2, C(2)ArC(2,6)H), 7.39 
(2H, d, J 8.2, C(2)ArC(3,5)H); 13C{1H} NMR (125 MHz, CDCl3) 
δC: 39.4 (C(4)), 45.5 (C(3)), 51.8 (C(5)O2CH3), 52.5 (C(1)O2CH3), 
57.0 (C(2)), 124.1 (q, 1JCF 271.9, CF3), 125.3 (q, 
3JCF 3.7, 
C(2)ArC(3,5)) 127.1 (ArC), 128.1 (ArC), 128.5 (ArC), 129.1 (ArC), 
129.6 (q, 2JCF 32.4, C(2)ArC(4)), 139.7 (C(2)ArC(1)), 140.7 
(C(3)ArC(1)), 171.8 (C(5)), 172.8 (C(1)); 19F{1H} NMR (470 MHz, 
CDCl3) δF: −62.6; HRMS (NSI
+) C20H20O4F3 [M+H]
+, found 
381.1309, requires 381.1308 (+0.2 ppm). 
Dimethyl (2R,3R)-2-(4-fluorophenyl)-3-phenylpentanedioate 
16. Following general procedure C, 2-(4-fluorophenyl)acetic acid 
(92.5 mg, 0.60 mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl 
chloride (111 μL, 0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 
(2S,3R)-5 (6.16 mg, 0.02 mmol, 5 mol%), (E)-1,1,1-trichloro-4-
phenylbut-3-en-2-one 7 (99.8 mg, 0.40 mmol), i-Pr2NEt (104 μL, 
0.60 mmol), MeOH (4 mL) and DMAP (9.76 mg, 0.08 mmol) gave 
the crude product (90:10 dr anti:syn). Column chromatography 
(80:20 Hexane:EtOAc, Rf = 0.27) gave the title compound 16 (91.0 
mg, 69%) as a white solid (>98:2 dr anti:syn) with spectroscopic 
data in accordance with the literature.13 mp 84−85 °C; {Lit.13 mp 
86−88 °C}; 
20
D
][  −114.3 (c 0.7 CHCl3); {Lit.
13 
20
D
][  −119.5 (c 0.2 
CHCl3) for 98% ee (2R,3R) stereoisomer}; Chiral HPLC analysis, 
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Chiralpak AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 
°C) tR(2S,3S): 11.7 min, tR(2R,3R): 13.5 min, 99% ee; 
1H NMR (300 
MHz, CDCl3) δH: 2.74−2.83 (2H, m, C(4)HH and C(4)HH), 3.51 
(3H, s, C(5)O2CH3), 3.70 (3H, s, C(1)O2CH3), 3.80−3.86 (2H, m, 
C(2)H and C(3)H), 6.77−6.85 (2H, m, ArCH), 6.95−6.99 (2H, m, 
ArCH), 7.03−7.15 (5H, m, ArCH); 19F{1H} NMR (282 MHz, 
CDCl3) δF: −115.6. 
Dimethyl (2R,3R)-3-phenyl-2-(3-tolyl)pentanedioate 17. 
Following general procedure C, m-tolylacetic acid (90 mg, 0.6 
mmol), i-Pr2NEt (156 μL, 0.90 mmol, pivalolyl chloride (111 μL 
0.90 mmol), in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 
mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 7 (99.8  mg, 0.40 
mmol), i-Pr2NEt (104 μL, 0.60 mmol) and MeOH (5 mL) gave the 
crude product (92:8 dr anti:syn). Column chromatography (90:10 
Petrol: EtOAc, Rf = 0.22) gave the title compound 17 (79 mg, 60%) 
as a white solid (>98:2 dr anti:syn) with spectroscopic data in 
accordance with the literature.13 Mp 72−74 oC {Lit.13 73−75 oC}; 
20
D
][  −135.0 (c 0.1 CHCl3); {Lit.
13 
20
D
][  −127.4 (c 0.1 CHCl3) for 
99% ee (2R, 3R) stereoisomer}; Chiral HPLC analysis, Chiralpak 
AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 oC) tR(2S, 
3S): 8.7 min, tR (2R, 3R): 10.4 min, 99% ee; 
1H NMR (500 MHz, 
CDCl3) δH: 2.21 (3H, s, ArCH3), 2.79−2.84 (2H, m, C(4)HH and 
C(4)HH), 3.51 (3H, s, C(5)O2CH3), 3.68 (3H, s, C(1)O2CH3), 
3.80−3.88 (2H, m, C(2)H and C(3)H), 6.90−6.92 (2H, m, ArH), 6.94 
(1H, br s, C(2)Ar(2)H), 7.00−7.07 (4H, m, ArH), 7.10−7.13 (2H, m, 
ArH).  
Dimethyl (2R,3R)-3-phenyl-2-(thiophen-3-yl)pentanedioate 
19. Following general procedure C, 3-thiophene acetic acid (85 mg, 
0.6 mmol), i-Pr2NEt (156 μL, 0.90 mmol, pivalolyl chloride (111 μL 
0.90 mmol), in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 
mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 7 (99.8  mg, 0.40 
mmol), i-Pr2NEt (104 μL, 0.60 mmol) and MeOH (5 mL) gave the 
crude product (81:19 dr anti:syn). Column chromatography (90:10 
Petrol: EtOAc, Rf = 0.25) gave the title compound 19 (81 mg, 64%) 
as a white solid (>98:2 dr anti:syn) with spectroscopic data in 
accordance with the literature.13 Mp 61−64 oC {Lit.13 60−64 oC}; 
20
D
][  −72.0 (c 0.5 CHCl3); {Lit.
13 
20
D
][  −69.0 (c 0.5 CHCl3) for 
97% ee (2R,3R) stereoisomer}; Chiral HPLC analysis, Chiralpak 
AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 oC) 
tR(2R,3R): 16.9 min, tR (2S,3S): 18.3 min, >99% ee; 
1H NMR (500 
MHz, CDCl3) δH: 2.75−2.83 (2H, m, C(4)HH and C(4)HH), 3.52 
(3H, s, C(5)O2CH3), 3.71 (3H, s, C(1)O2CH3), 3.77−3.82 (1H, m, 
C(3)H), 4.00 (1H, d, J 10.2, C(2)H), 6.85 (1H, dd, J 1.1, 5.0, 
C(2)ArH), 6.91 (1H, dd, J 1.0, 2.9, C(2)ArH), 7.00−7.02 (2H, m, 
C(3)ArH), 7.09−7.12 (2H, m, ArH), 7.14−7.17 (2H, m, ArH).  
Dimethyl (2S,3R)-3-phenyl-2-((E)-prop-1-en-1-yl)pentane-
dioate 20. Following general procedure C, 3-pentenoic acid (61 μL, 
0.6 mmol), i-Pr2NEt (156 μL, 0.90 mmol, pivalolyl chloride (111 μL 
0.90 mmol), in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 
mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 7 (99.8  mg, 0.40 
mmol), i-Pr2NEt (104 μL, 0.60 mmol) and MeOH (5 mL) gave the 
crude product (85:15 dr anti:syn). Column chromatography (90:10 
Petrol: EtOAc, Rf = 0.25) gave the title compound 20 (86 mg, 78%) 
as a colourless oil (>98:2 dr anti:syn) with spectroscopic data in 
accordance with the literature.13 
20
D
][  −67.3 (c 0.5 CHCl3); {Lit.
13 
20
D
][  −69.0 (c 0.5 CHCl3) for >99% ee (2S,3R) stereoisomer}; 
Chiral HPLC analysis, Chiralpak OD-H (97:3 hexane:IPA, flow rate 
1 mLmin-1, 220 nm, 30 oC) tR(2R,3S): 9.82 min, tR (2S,3R): 15.5 
min, >99% ee; 1H NMR (500MHz, CDCl3) δH 1.55 (3H, dd, J 1.3, 
6.3, C(2)C(3’)H), 2.69 (2H, d, J 7.6, C(4)H), 3.27 (1H, d, J 8.7, 
C(3)H), 3.52−3.62 (4H, m, C(2)H and C(5)O2CH3), 3.67 
(C(1)O2CH3), 5.22−5.44 (2H, m, C(2)C(1’)H and C(2)C(2’)H), 
7.09−7.12 (2H, m, C(3)ArH), 7.18−7.29 (3H, m, C(3)ArH).  
Dimethyl (2S,3R)-3-phenyl-2-((E)-3-phenylprop-1-en-1-yl)-
pentanedioate 21. Following general procedure C, (E)-5-
phenylpent-3-enoic acid (106 mg, 0.60 mmol), i-Pr2NEt (156 μL, 
0.90 mmol), pivaloyl chloride (111 μL, 0.90 mmol) in CH2Cl2 (4 
mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 mmol, 5 mol%), (E)-
1,1,1-trichloro-4-phenylbut-3-en-2-one 7 (99.8  mg, 0.40 mmol), i-
Pr2NEt (104 μL, 0.60 mmol), MeOH (4 mL) and DMAP (9.76 mg, 
0.08 mmol) gave the crude product (95:5 dr anti:syn). Column 
chromatography (80:20 Petrol:Et2O, Rf = 0.25) gave the title 
compound 21 (105 mg, 74%) as a colourless oil (>98:2 dr anti:syn) 
with spectroscopic data in accordance with the literature.13 
20
D
][  
−6.7 (c 1.0 CHCl3); {Lit.
13 
20
D
][  −6.9 (c 1.0 CHCl3) for >99% ee 
(2S,3R) stereoisomer}; Chiral HPLC analysis, Chiralcel OJ-H (99:1 
hexane:IPA, flow rate 1 mLmin-1, 211 nm, 40 °C) tR(2S,3R): 44.0 
min, tR(2R,3S): 48.4 min, 99% ee; 
1H NMR (400 MHz, CDCl3) δH: 
2.69 (2H, app. d, J 7.5, C(4)HH and C(4)HH), 3.20 (2H, app. d, J 
6.3, C(2)C(3’)HH and C(2)C(3’)HH), 3.33 (1H, t, J 9.3, C(2)H), 
3.53 (3H, s, C(5)O2CH3), 3.57−3.63 (1H, m, C(3)H), 3.71 (3H, s, 
C(1)O2CH3), 5.34 (1H, ddt, J 15.3, 9.3, 1.3, C(2)C(1’)H), 5.42−5.53 
(1H, m, C(2)C(2’)H), 6.75−6.79 (2H, m, ArCH), 7.11−7.32 (8H, m, 
ArCH). 
Dimethyl (2R,3R)-3-(4-methoxyphenyl)-2-phenylpentane-
dioate 23. Following general procedure C, phenylacetic acid (81.75 
mg, 0.60 mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl chloride 
(111 μL, 0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 
mg, 0.02 mmol, 5 mol%), (E)-1,1,1-trichloro-4-(4-
methoxyphenyl)but-3-en-2-one 42 (112 mg, 0.40 mmol), i-Pr2NEt 
(104 μL, 0.60 mmol), MeOH (4 mL) and DMAP (9.76 mg, 0.08 
mmol) gave the crude product (90:10 dr anti:syn). Column 
chromatography (80:20 Hexane:EtOAc, Rf = 0.29) gave the title 
compound 23 (99.0 mg, 73%) as a thick colourless oil (96:4 dr 
anti:syn) with spectroscopic data in accordance with the literature.13 
20
D
][  −98.5 (c 0.5 CHCl3); {Lit.
13 
20
D
][  −105.7 (c 0.2 CHCl3) for 
99% ee (2R,3R) stereoisomer}; Chiral HPLC analysis, Chiralpak 
AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 °C) 
tR(2S,3S): 18.7 min, tR(2R,3R): 20.1 min, >99% ee; 
1H NMR (300 
MHz, CDCl3) δH: 2.70−2.84 (2H, m, C(4)HH and C(4)HH), 3.51 
(3H, s, C(5)O2CH3), 3.68 (6H, s, C(1)O2CH3 and C(3)ArOCH3), 
3.77−3.84 (2H, m, C(2)H and C(3)H), 6.64 (2H, d, J 8.7, 
C(3)ArC(3,5)H), 6.91 (2H, d, J 8.7, C(3)ArC(2,6)H), 7.10−7.15 (5H, 
m, C(2)ArCH).  
Dimethyl (2R,3R)-3-(2-nitrophenyl)-2-phenylpentanedioate 
24. Following general procedure C, phenylacetic acid (81.6 mg, 0.60 
mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl chloride (111 μL, 
0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 
mmol, 5 mol%), (E)-1,1,1-trichloro-4-(2-nitrophenyl)but-3-en-2-one 
43 (118 mg, 0.40 mmol), i-Pr2NEt (104 μL, 0.60 mmol), MeOH (4 
mL) and DMAP (9.76 mg, 0.08 mmol) gave the crude product (95:5 
dr anti:syn). Column chromatography (65:35 Petrol:Et2O, Rf = 0.25) 
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gave the title compound 24 (114 mg, 80%) as a light yellow solid 
(>98:2 dr anti:syn). mp 76−78 °C; 
20
D
][  −106.6 (c 1.0 CHCl3); 
Chiral HPLC analysis, Chiralpak AD-H (95:5 hexane:IPA, flow rate 
1 mLmin-1, 211 nm, 30 °C) tR(2S,3S): 29.0 min, tR(2R,3R): 31.1 min, 
>99% ee; νmax (ATR) 2957 (C-H), 1725 (C=O), 1526 (N-O), 1354 
(N-O); 1H NMR (400 MHz, CDCl3) δH: 2.88 (1H, dd, J 15.9, 4.4, 
C(4)HH), 2.98 (1H, dd, J 15.9, 10.0, C(4)HH), 3.52 (3H, s, 
C(5)O2CH3), 3.67 (3H, s, C(1)O2CH3), 4.14 (1H, d, J 9.5, C(2)H), 
4.56 (1H, td, J 9.7, 4.4, C(3)H), 7.13−7.26 (6H, m, ArCH), 
7.37−7.47 (2H, m, ArCH), 7.63 (1H, dd, J 8.1, 1.3, C(3)ArC(3)H); 
13C{1H} NMR (125 MHz, CDCl3) δC: 38.1 (C(4)), 39.4 (C(3)), 51.9 
(C(5)O2CH3), 52.4 (C(1)O2CH3), 57.8 (C(2)), 124.6 (C(3)ArC(3)H), 
127.8 (C(2)ArC(4)H), 128.6 (C(2)ArC(3,5)H and C(3)ArC(4)H), 
128.7 (C(2)ArC(2,6)H and C(3)ArC(6)H), 132.5 (C(3)ArC(5)H), 
135.2 (C(3)ArC(1)), 136.0 (C(2)ArC(1)), 150.7 (C(3)ArC(2)), 171.5 
(C(5)), 172.8 (C(1)); HRMS (NSI+) C19H20NO6 [M+H]
+, found 
358.1285, requires 358.1285 (0.0 ppm). 
Dimethyl (2R,3R)-3-(4-fluorophenyl)-2-phenylpentanedioate 
25. Following general procedure C, phenylacetic acid (81.6 mg, 0.60 
mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl chloride (111 μL, 
0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 
mmol, 5 mol%), (E)-1,1,1-trichloro-4-(4-fluorophenyl)but-3-en-2-
one 44 (107 mg, 0.40 mmol), i-Pr2NEt (104 μL, 0.60 mmol), 
methanol (4 mL) and DMAP (9.76 mg, 0.08 mmol) gave the crude 
product (87:13 dr anti:syn). Column chromatography (75:25 
Petrol:Et2O, Rf = 0.25) gave the title compound 25 (92.0 mg, 70%) 
as a colourless oil (>98:2 dr anti:syn) with spectroscopic data in 
accordance with the literature.13 
20
D
][  −119.6 (c 0.75 CHCl3); 
{Lit.13 
20
D
][  −114.3 (c 0.1 CHCl3) for 98% ee (2R,3R) 
stereoisomer}; Chiral HPLC analysis, Chiralcel OD-H (95:5 
hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 °C) tR(2R,3R): 10.2 
min, tR(2S,3S): 11.1 min, 99% ee; 
1H NMR (500 MHz, CDCl3) δH: 
2.75 (1H, dd, J 15.4, 10.0, C(4)HH), 2.82 (1H, dd, J 15.4, 4.4, 
C(4)HH), 3.52 (3H, s, C(5)O2CH3), 3.69 (3H, s, C(1)O2CH3), 3.79 
(1H, d, J 10.9, C(2)H), 3.86 (1H, app. td, J 10.4, 4.4, C(3)H), 
6.77−6.82 (2H, m, C(3)ArC(3,5)H), 6.94−6.97 (2H, m, 
C(3)ArC(2,6)H), 7.08−7.17 (5H, m, ArCH); 19F{1H} NMR (470 
MHz, CDCl3) δF: −115.92 (C(3)ArC(4)F). 
Dimethyl (2R,3R)-3-(furan-2-yl)-2-phenylpentanedioate 26. 
Following general procedure C, phenylacetic acid (81.7 mg, 0.60 
mmol), i-Pr2NEt (156 μL, 0.90 mmol), pivaloyl chloride (111 μL, 
0.90 mmol) in CH2Cl2 (4 mL), HBTM-2.1 (2S,3R)-5 (6.16 mg, 0.02 
mmol, 5 mol%), (E)-1,1,1-trichloro-4-(furan-2-yl)but-3-en-2-one 45 
(95.8 mg, 0.40 mmol), i-Pr2NEt (104 μL, 0.60 mmol), MeOH (4 mL) 
and DMAP (9.76 mg, 0.08 mmol) gave the crude product (80:20 dr 
anti:syn). Column chromatography (90:10 Hexane:EtOAc, Rf = 
0.14) gave the title compound 26 (97.0 mg, 80%) as a colourless oil 
(80:20 dr anti:syn). 
20
D
][  −75.6 (c 0.6 CHCl3); νmax (ATR) 2953, 
1730, 1454, 1435, 1350, 1269, 1148; Data for major anti 
diastereoisomer: Chiral HPLC analysis, Chiralpak AD-H (95:5 
hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 °C) tR(2S,3S): 10.9 
min, tR(2R,3R): 12.3 min, 98% ee; 
1H NMR (500 MHz, CDCl3) δH: 
2.71-2.74 (1H, m, C(4)HAHB), 2.81−2.89 (1H, m, C(4)HAHB), 3.61 
(3H, s, C(5)O2CH3), 3.69 (3H, s, C(1)O2CH3), 3.97−4.02 (2H, m, 
C(2)H and C(3)H), 5.81 (1H, dd, J 3.3, 0.6, C(3)ArC(3)H), 6.06 
(1H, dd, J 3.3, 1.9, C(3)ArC(4)H), 7.15−7.25 (6H, m, C(2)ArCH and 
C(3)ArC(5)H); 13C{1H} NMR (125 MHz, CDCl3) δC: 36.9 (C(4)), 
39.4 (C(3)), 51.8 (C(5)O2CH3), 52.3 (C(1)O2CH3), 55.0 (C(2)), 
107.5 (C(3)ArC(3)), 110.0 (C(3)ArC(4)), 127.5 (C(2)ArC), 128.3 
(C(2)ArC), 128.4 (C(2)ArC), 136.5 (C(2)ArC(1)), 141.4 
(C(3)ArC(5)), 153.3 (C(3)ArC(1)), 171.8 (C(5)), 173.0 (C(1)); Data 
for minor syn diastereoisomer: Chiral HPLC analysis, Chiralpak 
AD-H (95:5 hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 °C) 
tR(major): 13.8 min, tR(minor): 16.9 min, 23% ee; 
1H NMR (500 
MHz, CDCl3) δH: 2.38 (1H, dd, J 15.7, 4.4, C(4)H
AHB), 2.46 (1H, 
dd, J 15.7, 9.6, C(4)HAHB), 3.50 (3H, s, C(5)O2CH3), 3.51 (3H, s, 
C(1)O2CH3), 4.03−4.09 (2H, m, C(2)H and C(3)H), 6.16 (1H, d, J 
3.2, C(3)ArC(3)H), 6.27 (1H, dd, J 3.2, 1.9, C(3)ArC(4)H), 
7.27−7.42 (6H, m, C(2)ArCH and C(3)ArC(5)H); 13C{1H} NMR 
(125 MHz, CDCl3) δC: 36.1 (C(4)), 38.7 (C(3)), 51.6 (C(5)O2CH3), 
52.1 (C(1)O2CH3), 55.2 (C(2)), 106.8 (C(3)ArC(3)), 110.3 
(C(3)ArC(4)), 128.1 (C(2)ArC), 128.7 (C(2)ArC), 129.0 (C(2)ArC), 
136.0 (C(2)ArC(1)), 141.8 (C(3)ArC(5)), 154.4 (C(3)ArC(1)), 171.9 
(C(5)), 172.8 (C(1)); HRMS (NSI+) C17H19O5 [M+H]
+, found 
303.1228, requires 303.1227 (+0.3 ppm).  
(3R,4R)-4-Pentyl-3-phenyl-6-(trichloromethyl)-3,4-dihydro-
2H-pyran-2-one 27. Phenylacetic acid (81.7 mg, 0.60 mmol) was 
dissolved in CH2Cl2 (4 mL) before i-Pr2NEt (156 μL, 0.90 mmol) 
and pivaloyl chloride (111 μL, 0.90 mmol) were added. After 
stirring at rt for 5 min the solution was cooled to −78 °C and HBTM-
2.1 (2S,3R)-5 6.16 mg, 0.02 mmol, 5 mol%), (E)-1,1,1-trichloronon-
3-en-2-one 46 (97 mg, 0.40 mmol), i-Pr2NEt (104 μL, 0.60 mmol) 
were added in succession. The reaction mixture was stirred at −78 
°C for 16 h before being concentrated under reduced pressure and 
purified by column chromatography (neat hexane to 96:4 
hexane:EtOAc, Rf = 0.20) to give the title compound 27 (105 mg, 
71%) as a white solid (94:6 dr anti:syn). mp 42−44 °C; 
20
D
][  −62.1 
(c 1.0 CHCl3); Chiral HPLC analysis, Chiralpak AD-H (99:1 
hexane:IPA, flow rate 1 mLmin-1, 211 nm, 30 °C) tR(2R,3R): 15.9 
min, tR(2S,3S): 17.7 min, 86% ee; νmax (ATR) 2955, 2928, 2859, 
1778, 1497, 1454, 1173, 1155, 1115, 1101; 1H NMR (300 MHz, 
CDCl3) δH: 0.87 (3H, t, J 6.7, CH3), 1.24−1.50 (8H, m, (CH2)4), 
2.81-2.89 (1H, m, C(4)H), 3.68 (1H, d, J 8.1, C(3)H), 6.20 (1H, d, J 
4.2, C(5)H), 7.19−7.24 (2H, m, ArC(2,6)H), 7.29−7.42 (3H, m, 
ArC(3,4,5)H); 13C{1H} NMR (100 MHz, CDCl3) δC: 14.1 (CH3), 
22.5 (CH2), 25.8 (CH2), 31.6 (CH2), 32.9 (CH2), 38.1 (C(4)H), 49.9 
(C(3)H), 90.2 (CCl3), 108.4 (C(5)H), 128.2 (ArC(4)H), 128.2 
(ArC(2,6)H), 129.1 (ArC(3,5)H), 135.7 (ArC(1)), 148.2 (C(6)), 
167.4 (C(2)); HRMS (NSI+) C17H18
35Cl3O2 [M+H]
+, found 
359.0369, requires 359.0367 (+0.6 ppm).  
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